A Phase 1 clinical trial to evaluate obinutuzumab with high-dose ibrutinib for the treatment of patients with chronic lymphocytic leukemia with progressive disease on single agent ibrutinib

UCI-16-65
NCT02611908
Cancer - Lymphoid Leukemia
Deepa Jeyakumar
Open
Treatment
Ibrutinib, Obinutuzumab (GA101)
I
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.